|1|Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review. (22511434)
De Berardinis E.... Gentile V.
|2|Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review. (22759317)
Rai B.P.... Nabi G.
|3|Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor. (23018212)
Ali R.H.... Gilks C.B.
|4|Prognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder. (21346826)
Abd Elazeez T.A.... Abdul-Halim H.
|5|Ureterectomy and ureteral reimplatation for low-grade transitional cell carcinoma: is the laparoscopic approach feasible and effective? (21826883)
Maestroni U.... Ziglioli F.
|6|Transitional cell carcinoma of the native urinary tract after kidney transplantation: recommendations following a long-term retrospective analysis. (21412138)
Tsaur I.... Probst M.
|7|Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17. (19443884)
Simonetti S.... Insabato L.
|8|Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter. (19190765)
Kundu S.D.... Eggener S.E.
|9|Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium. (19773726)
Ecke T.D.... Ruttloff J.
|10|Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. (19033864)
Cuatrecasas M.... Prat J.
|11|Transitional cell carcinoma in renal transplant recipients: a single center experience. (18184173)
Li X.B.... Zhang X.D.
|12|Transitional cell carcinoma of the urinary bladder: a clinicopathological study. (18946612)
Matalka I.... Bani-Hani I.
|13|Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207. (18272914)
Rosenberg J.E.... Small E.J.
|14|Upper urinary tract transitional cell carcinoma. A 10-year experience. (18468339)
Papatsoris A.G.... Deliveliotis C.
|15|Adenoviral receptor expression of normal bladder and transitional cell carcinoma of the bladder. (17293658)
Buscarini M.... Bochner B.
|16|Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group. (17011058)
Gogna N.K.... Tripcony L.
|17|Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography. (15989448)
Manyak M.J.... Feldchtein F.I.
|18|Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. (16361539)
Raman J.D.... Gudas L.J.
|19|A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9]. (15518131)
Matsuoka Y.... Ito Y.
|20|Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma. (15450303)
Li G.... Zhang Y.
|21|Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder. (14685796)
Lekili M.... BA1yA1ksu C.
|22|Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas. (14981907)
Chuang C.K.... Liao S.K.
|23|Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome. (12796695)
Hausladen D.A.... Weiss R.M.
|24|Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma. (12576464)
Inoue K.... Shuin T.
|25|Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder. (11834417)
Staack A.... Jung K.
|26|p53 and bcl-2 overexpression as associated risk factors in patients 40 years old or less with transitional cell carcinoma of the bladder. (11464113)
Asci R.... Kandemir B.
|27|Urinary cytokeratin 20 as a marker for transitional cell carcinoma. (10765100)
Rotem D.... Stein A.
|28|Correlative expression of glutathione S-transferase-pi and multidrug resistance associated protein in bladder transitional cell carcinoma. (12840920)
Yang W.... Du G.
|29|Screening for transitional cell carcinoma of the bladder with trophoblastic differentiation in Upper Galilee]. (10909500)
Moldavsy M.... Turani H.
|30|Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma. (9818021)
Yuasa T.... Okada Y.
|31|Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2. (9477105)
Vollmer R.T.... Hudson M.L.
|32|Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma. (10210109)
Akpolat I.... Kandemir B.
|33|Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder. (9477184)
Ogura K.... Yoshida O.
|34|Flow cytometric evaluation of transferrin receptor in transitional cell carcinoma. (9373912)
Rahman S.A.... Takeuchi M.
|35|A hot spot for p53 mutation in transitional cell carcinoma of the bladder: clues to the etiology of bladder cancer. (9264274)
Xu X.... Burns P.A.
|36|Results at 43 months' follow-up of a double-blind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pT1 transitional cell carcinoma of the bladder. (9037279)
Portillo J.... Gutierrez R.
|37|Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder]. (9275651)
Yu D.... Liang Z.
|38|Expression of CD44 splice variants in human transitional cell carcinoma. (8740026)
Takada S.... Okuyama A.
|39|Overexpression of C-erbB3 in transitional cell carcinoma of the ovary]. (8745489)
Shen K.... Guo L.
|40|Transitional cell carcinoma of the renal pelvis with choriocarcinomatous differentiation. Immunohistochemical and immunoelectron microscopic assessment of human chorionic gonadotropin production by transitional cell carcinoma of the urinary bladder. (8448745)
Grammatico D.... Walton J.C.
|41|The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinoma. (8171764)
van Moorselaar R.J.... Schalken J.A.
|42|Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas. (1739130)
Abruzzo L.V.... Kunkel S.L.
|43|Primary localized amyloidosis of the renal pelvis coexisting with transitional cell carcinoma: a case report. (1632328)
Shiramizu M.... Kinoshita H.
|44|c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized, high-grade transitional cell carcinoma of the bladder. (1364264)
Swanson P.E.... Wick M.R.
|45|Transitional cell carcinoma in a urethral diverticulum. (1586346)
Catalano S.... Jones I.
|46|Epidermal nevus with transitional cell carcinomas of the urinary tract. (1802914)
Rongioletti F.... Rebora A.
|47|Renal transitional cell carcinoma mimicking medullary sponge kidney. (2021801)
Choong M.... Phillips G.W.
|48|ABO(H) antigens and beta-2 microglobulin in transitional cell carcinoma. Predictors of response to intravesical bacillus Calmette-Guerin. (1710534)
Sanders H.... Graham S.D.
|49|Correlation of the expression of A, B isoantigens with its precursor H antigen in transitional cell carcinoma and the clinical signification of the expression]. (2086062)
|50|Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa. (3121867)
Wood D.P.... Levin H.S.